Vince Ippolito
Botanix Pharma – Tell Us Is It Good or Bad?
Yesterday, Botanix Pharma (ASX:BOT), released top-line data from their Phase 2 study evaluating the safety and efficacy of their drug in patients with moderate to severe acne. Bot...
25 May
13 min read
Botanix Pharma – ready for lift-off in 2020
Botanix Pharma - one of our strongest cannabis stock picks - had an issue with its Acne drug Phase 2 results. We speak exclusively to the company and hear - first hand - how they h...
20 Apr
10 min read
About Pot Stocks
Learn more about the biggest pot stocks making headlines. We provide a constant stream of breaking news, in-depth analysis, and valuable insight into the marijuana market.
Get Started
